Chamseddine, Reem S.
Wang, Cathy
Yin, Kanhua https://orcid.org/0000-0002-4769-3129
Wang, Jin
Singh, Preeti
Zhou, Jingan
Robson, Mark E.
Braun, Danielle
Hughes, Kevin S.
Funding for this research was provided by:
national institutes of health (5T32CA009337-40)
Article History
Received: 30 July 2021
Accepted: 30 September 2021
First Online: 13 October 2021
Declarations
:
: KSH receives Honoraria from Hologic (surgical implant for radiation planning with breast conservation and wire-free breast biopsy) and Myriad Genetics and is a founder and has financial interest in CRA Health (Formerly Hughes RiskApps, cancer risk assessment software), which was recently acquired by Volpara (breast density and cancer risk assessment company). KSH is the co-creator of Ask2Me.Org (a genetic risk KnowledgeBase), which Mass General Brigham licenses to MedNeon (a cancer risk assessment company). KSH’s interests were reviewed and are managed by Massachusetts General Hospital and Mass General Brigham Healthcare in accordance with their conflict of interest policies. DB co-leads the BayesMendel laboratory, which licenses software for the computation of risk prediction models. She does not currently derive any personal income from these licenses. DB is also co-inventor of Ask2Me.Org. The other authors declare that they have no conflict of interest.
: This study was based on literature review and did not involve human participants.
: Not applicable.